Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
PGEN Precigen Inc
- Stocks
- Healthcare
- NASDAQ: PGEN
Price (delayed)
$1.45
Market cap
$428.01M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.56
Enterprise value
$427.37M
Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases
Highlights
PGEN's gross margin has soared by 75% from the previous quarter and by 48% YoY
PGEN's gross profit has surged by 73% since the previous quarter and by 60% year-on-year
PGEN's quick ratio has soared by 112% YoY but it is down by 26% from the previous quarter
Precigen's revenue has decreased by 23% YoY but it has increased by 7% from the previous quarter
PGEN's equity has dropped by 137% since the previous quarter and by 114% year-on-year
PGEN's net income has dropped by 62% year-on-year and by 24% since the previous quarter
Key stats
What are the main financial stats of PGEN
Market
Valuations
Earnings
Shares outstanding
295.18M
Market cap
$428.01M
Enterprise value
$427.37M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
101.43
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
101.73
Revenue
$4.2M
Gross profit
-$91,000
Operating income
-$133.22M
Net income
-$156.65M
EBIT
-$158.41M
EBITDA
-$154.85M
Free cash flow
-$75.21M
Per share
Balance sheet
Liquidity
EPS
-$0.56
EPS diluted
-$0.56
Free cash flow per share
-$0.26
Book value per share
-$0.05
Revenue per share
$0.01
TBVPS
$0.36
Total assets
$128.79M
Total liabilities
$113.33M
Debt
$5.42M
Equity
-$14.06M
Working capital
$60.62M
Debt to equity
-0.39
Current ratio
3.53
Quick ratio
3.39
Net debt/EBITDA
0
Margins
Efficiency
Dividend
EBITDA margin
-3,686%
Gross margin
-2.2%
Net margin
-3,728.9%
Operating margin
-3,171%
Return on assets
-145.5%
Return on equity
-509.4%
Return on invested capital
-337.5%
Return on capital employed
-151.2%
Return on sales
-3,770.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PGEN stock price
How has the Precigen stock price performed over time
Intraday
10.69%
1 week
9.02%
1 month
5.84%
1 year
3.57%
YTD
29.46%
QTD
-2.68%
Financial performance
How have Precigen's revenue and profit performed over time
Revenue
$4.2M
Gross profit
-$91,000
Operating income
-$133.22M
Net income
-$156.65M
Gross margin
-2.2%
Net margin
-3,728.9%
Precigen's net margin has plunged by 109% YoY and by 16% from the previous quarter
PGEN's gross margin has soared by 75% from the previous quarter and by 48% YoY
PGEN's gross profit has surged by 73% since the previous quarter and by 60% year-on-year
PGEN's operating margin has plunged by 71% YoY but it is up by 8% from the previous quarter
Price vs fundamentals
How does PGEN's price correlate with its fundamentals
Growth
What is Precigen's growth rate over time
Valuation
What is Precigen stock price valuation
P/E
N/A
P/B
N/A
P/S
101.43
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
101.73
Precigen's EPS has decreased by 44% YoY and by 19% QoQ
PGEN's equity has dropped by 137% since the previous quarter and by 114% year-on-year
PGEN's P/S is 92% below its 5-year quarterly average of 1260.1 but 20% above its last 4 quarters average of 84.4
Precigen's revenue has decreased by 23% YoY but it has increased by 7% from the previous quarter
Efficiency
How efficient is Precigen business performance
The ROA has plunged by 157% YoY and by 26% from the previous quarter
PGEN's return on equity has dropped by 136% since the previous quarter
The ROIC has plunged by 123% YoY but it has grown by 10% from the previous quarter
Precigen's return on sales has shrunk by 111% YoY and by 16% QoQ
Dividends
What is PGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PGEN.
Financial health
How did Precigen financials performed over time
The company's total assets is 14% higher than its total liabilities
PGEN's total liabilities has soared by 200% YoY and by 44% from the previous quarter
PGEN's quick ratio has soared by 112% YoY but it is down by 26% from the previous quarter
Precigen's debt is 139% more than its equity
PGEN's equity has dropped by 137% since the previous quarter and by 114% year-on-year
Precigen's debt has decreased by 19% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.